No Data
No Data
Amwell to Report Second Quarter 2024 Operating Results
Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell (NYSE:AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31. Following the distribution of the
Express News | American Well- on July 10, Effected Reverse Stock Split of Class a Common Stock, Class B Common Stock & Class C Common Stock at Ratio of 1-for-20
Italy Telehealth Market Outlook to 2033, Featuring Teladoc Health and American Well Corporation
Morgan Stanley Maintains American Well(AMWL.US) With Hold Rating, Maintains Target Price $20
Morgan Stanley analyst Craig Hettenbach maintains $American Well(AMWL.US)$ with a hold rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 59.2%
Analysts' Top Healthcare Picks: Astellas Pharma (ALPMF), American Well (AMWL)
Morgan Stanley Sticks to Their Hold Rating for American Well (AMWL)
No Data